HU9403299D0 - Melatonin for use in treating desynchronisation disorders - Google Patents

Melatonin for use in treating desynchronisation disorders

Info

Publication number
HU9403299D0
HU9403299D0 HU9403299A HU9403299A HU9403299D0 HU 9403299 D0 HU9403299 D0 HU 9403299D0 HU 9403299 A HU9403299 A HU 9403299A HU 9403299 A HU9403299 A HU 9403299A HU 9403299 D0 HU9403299 D0 HU 9403299D0
Authority
HU
Hungary
Prior art keywords
treating
disorders
desynchronisation
melatonin
pharmaceutical formulations
Prior art date
Application number
HU9403299A
Other languages
English (en)
Other versions
HUT72070A (en
Inventor
Michael Edward Flaugh
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of HU9403299D0 publication Critical patent/HU9403299D0/hu
Publication of HUT72070A publication Critical patent/HUT72070A/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HU9403299A 1993-11-18 1994-11-17 Pharmaceutical compositions containing melatonin derivatives for treating desynchronization disorders HUT72070A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/154,903 US6180657B1 (en) 1993-11-18 1993-11-18 Melatonin derivatives for use in treating desynchronization disorders

Publications (2)

Publication Number Publication Date
HU9403299D0 true HU9403299D0 (en) 1995-01-30
HUT72070A HUT72070A (en) 1996-03-28

Family

ID=22553300

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9403299A HUT72070A (en) 1993-11-18 1994-11-17 Pharmaceutical compositions containing melatonin derivatives for treating desynchronization disorders

Country Status (21)

Country Link
US (1) US6180657B1 (hu)
EP (1) EP0656209B1 (hu)
JP (1) JPH07196504A (hu)
KR (1) KR950013509A (hu)
CN (1) CN1100533C (hu)
AT (1) ATE239470T1 (hu)
AU (1) AU7777694A (hu)
CA (1) CA2135710C (hu)
CZ (1) CZ288834B6 (hu)
DE (1) DE69432626T2 (hu)
DK (1) DK0656209T3 (hu)
ES (1) ES2197904T3 (hu)
HU (1) HUT72070A (hu)
IL (1) IL111579A (hu)
NO (1) NO307364B1 (hu)
NZ (1) NZ264893A (hu)
PT (1) PT656209E (hu)
RU (1) RU2160101C2 (hu)
SG (1) SG77569A1 (hu)
UA (1) UA35588C2 (hu)
ZA (1) ZA948928B (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0748627A3 (en) * 1995-06-14 1997-05-21 Lilly Co Eli Melatonin agonists for the treatment of benign forms of hyperplasia of the prostate
CA2551117A1 (en) * 2003-12-23 2005-07-14 Abraxis Bioscience, Inc. Substituted melatonin derivatives, process for their preparation, and methods of use
TWI402261B (zh) 2006-06-19 2013-07-21 Takeda Pharmaceutical 三環化合物及其醫藥組成物
JP2011520923A (ja) * 2008-05-19 2011-07-21 武田薬品工業株式会社 細胞傷害性抗癌モノクローナル抗体
US11918557B2 (en) 2012-01-26 2024-03-05 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
BR112014018429A8 (pt) 2012-01-26 2017-07-11 Vanda Pharmaceuticals Inc Método para tratar um paciente que sofre de não-24, e, método para o tratamento crônico de não-24 em uma pessoa que está totalmente cega
AU2013361459A1 (en) 2012-12-18 2015-07-02 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
RU2533965C1 (ru) * 2013-07-04 2014-11-27 Государственное бюджетное учреждение здравоохранения "Самарский областной гериатрический центр" Способ нормализации циркадианных ритмов человека
US11090285B2 (en) 2013-11-12 2021-08-17 Vanda Pharmaceuticals Inc Treatment of circadian rhythm disorders
US10376487B2 (en) 2013-11-12 2019-08-13 Vanda Pharmaceuticals Inc. Method of treatment
RU2655813C1 (ru) * 2017-06-09 2018-05-29 Федеральное государственное бюджетное учреждение науки "Институт токсикологии Федерального медико-биологического агентства" Средство коррекции и профилактики состояний, вызванных нарушением суточных ритмов

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087444A (en) 1976-09-08 1978-05-02 Eli Lilly And Company Amides as ovulation inhibitors
US4600723A (en) 1983-05-18 1986-07-15 Monash University Method for minimizing disturbances in circadian rhythms of bodily performance and function
DE3466215D1 (en) 1983-05-18 1987-10-22 Univ Monash The use of melatonin for the manufacture of a medicament
US4614807A (en) 1984-10-04 1986-09-30 Eli Lilly And Company 6,7-dihalomelatonins
US4687763A (en) 1985-02-25 1987-08-18 Massachusetts Institute Of Technology Composition and method for increasing levels or release of brain serotonin
IL79264A0 (en) 1986-06-27 1986-09-30 Univ Ramot Tryptamine derivatives,pharmaceutical compositions containing them and their use in an assay for melatonin receptors
US4997845A (en) 1987-02-02 1991-03-05 Eli Lilly And Company β-alkylmelatonins as ovulation inhibitors
EP0375726A4 (en) 1987-08-17 1991-01-30 Whitby Research Incorporated Melatonin analogues
US5093352A (en) 1988-11-14 1992-03-03 Whitby Research, Inc. Antidepressant agents
JPH0418034A (ja) * 1990-05-11 1992-01-22 Kanegafuchi Chem Ind Co Ltd 点眼組成物
US5242941A (en) 1990-12-04 1993-09-07 State Of Oregon Methods of treating circadian rhythm disorders
IT1251544B (it) 1991-05-13 1995-05-17 Gabriele Biella Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico
ZA928011B (en) * 1991-10-18 1993-06-23 Alza Corp Transdermal administration of melatonin.
US5196435A (en) 1991-11-21 1993-03-23 Eli Lilly And Company Melatonin derivatives and combinations with antiestrogen compounds for treating mammalian breast carcinoma
IT1255199B (it) * 1992-07-01 1995-10-20 Franco Fraschini Farmaco sintetizzato analogo della melatonina particolarmente efficacenelle patologie che interferiscono con i ritmi circadiani
IT1254995B (it) * 1992-06-24 1995-10-11 Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circandiani
US5449683A (en) * 1992-10-01 1995-09-12 Massachussetts Institute Of Technology Methods of inducing sleep using melatonin

Also Published As

Publication number Publication date
CN1100533C (zh) 2003-02-05
CN1107700A (zh) 1995-09-06
DE69432626D1 (de) 2003-06-12
CA2135710A1 (en) 1995-05-19
CA2135710C (en) 2007-07-10
IL111579A (en) 1999-10-28
UA35588C2 (uk) 2001-04-16
DE69432626T2 (de) 2004-04-08
US6180657B1 (en) 2001-01-30
EP0656209A2 (en) 1995-06-07
CZ288834B6 (cs) 2001-09-12
NO944340L (no) 1995-05-19
DK0656209T3 (da) 2003-09-01
IL111579A0 (en) 1995-01-24
HUT72070A (en) 1996-03-28
ES2197904T3 (es) 2004-01-16
NO944340D0 (no) 1994-11-14
CZ276494A3 (en) 1995-07-12
KR950013509A (ko) 1995-06-15
JPH07196504A (ja) 1995-08-01
PT656209E (pt) 2003-09-30
SG77569A1 (en) 2001-01-16
NZ264893A (en) 1997-06-24
AU7777694A (en) 1995-05-25
ATE239470T1 (de) 2003-05-15
EP0656209A3 (en) 1995-10-11
EP0656209B1 (en) 2003-05-07
ZA948928B (en) 1996-05-10
NO307364B1 (no) 2000-03-27
RU94041028A (ru) 1996-09-20
RU2160101C2 (ru) 2000-12-10

Similar Documents

Publication Publication Date Title
EP0751709A4 (en) METHODS FOR USE OF BCL-2 IN THERAPEUTIC TREATMENT AND PREVENTION OF DISEASES
IL107248A0 (en) Apparatus for treatment of the oral cavity
EP0651650A4 (en) METHOD FOR TREATING EYE DISEASES BY MEANS OF TGF - g (b).
GB2264235B (en) Composition for nasal treatment
GB2146527B (en) Use of benzothiophene derivatives as antiasthmatic agents
HU9403299D0 (en) Melatonin for use in treating desynchronisation disorders
SG50505A1 (en) Melatonin derivatives for use in treating sleep disorders
IL105957A0 (en) Handpiece for laser apparatus
IL105475A0 (en) Pharmaceutical compositions containing 1alpha,24(r)-dihydroxy-22(e)-dehydro-vitamin d3 for treating osteoporosis
EP0729734A3 (en) Laser treatment device
AP9200355A0 (en) "Therapeutic agent"
GB2265833B (en) Myopia therapy apparatus
IL100629A0 (en) Apparatus for the treatment of papulosquamous disorders
GB9226059D0 (en) Apparatus for medical treatment
GB2264249B (en) Apparatus for surface treatment
HU9500620D0 (en) Soft laser apparatus for medical therapy
AU7654196A (en) Spinal therapy apparatus

Legal Events

Date Code Title Description
FC4A Lapse of provisional application due to refusal